PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
15-Mar-2023 Aura Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights Businesswire
15-Mar-2023 Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress Businesswire
15-Mar-2023 ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022 Businesswire
15-Mar-2023 ADOCIA Announces Its Annual Results for 2022 and Provides Corporate and Financial Update Businesswire
15-Mar-2023 Zipline Unveils New Autonomous System Capable of Quiet, Fast and Precise Home Delivery Businesswire
15-Mar-2023 Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature Businesswire
15-Mar-2023 Inspire Biotherapeutics Launches with Pre-seed Investment to Target Monogenic and Acquired Lung Diseases with Proprietary AAVenger Gene Therapy Platform Businesswire
15-Mar-2023 Checkerspot’s Pollinator™ Kit for Renewable Design wins SXSW Innovation Award in the Design Category Businesswire
15-Mar-2023 IPS Strengthens Biologics Expertise with New Team Members, Brian Horowski and Bob Forbes Businesswire
15-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of G-III Apparel Group, Ltd. (GIII) on Behalf of Investors Businesswire
15-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Edgio, Inc. (EGIO) on Behalf of Investors Businesswire
15-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fidelity National Information Services, Inc. (FIS) on Behalf of Investors Businesswire
15-Mar-2023 Vaultree Launches Software Development Kit, Making Scalable Data-In-Use Encryption Generally Available to All Enterprises Businesswire
15-Mar-2023 Edgeworth Economics’ Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog Businesswire
15-Mar-2023 genXtraits Inc. Announces Closing of First Capital Raise Businesswire
15-Mar-2023 Cannabis Industry Webinar: Strategies to Survive and Thrive Businesswire
15-Mar-2023 Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds Businesswire
15-Mar-2023 ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio Businesswire
15-Mar-2023 FIRE1 Raises $25 Million to Revolutionize Heart Failure Home Monitoring Businesswire
15-Mar-2023 ReCode Therapeutics Announces First Participants Dosed in a Phase 1 Healthy Volunteer Clinical Trial of Novel Disease-Modifying Genetic Medicine, RCT1100 for the Treatment of Primary Ciliary Dyskinesia Businesswire